Medical technology company Synthetic MR reports increased revenue in the second quarter compared with the same period a year earlier. The operating loss narrowed.Revenue increased 12.9 percent to SEK 14.0 million (12.4).ARR, annual recurring revenue, increased by 5 percent to SEK 11.7 million (11.3).Operating profit was -SEK 6.5 million (-8.6). Net result after tax was -SEK 6.1 million (-10.4), and per share -SEK 0.06 (-0.16). Cash flow from operating activities amounted to -SEK 2.6 million (0.5). Cash and cash equivalents amounted to SEK 28.3 million (19.4)."The path to profitability is based on increased sales combined with cost control. Our ambition is for existing capital to be sufficient, and disciplined cost control is an important part of strengthening cash flow. Now it is about execution - translating the strength of our offering into sustainable growth and profitability", comments CEO Lena Åredal.Synthetic MR, SEK millionQ2-2026Q2-2025ChangeNet sales14.012.412.9%Operating profit-6.5-8.6Net result-6.1-10.4Earnings per share, SEK-0.06-0.16Cash flow from operating activities-2.60.5Cash and cash equivalents28.319.445.9%